Trials / Unknown
UnknownNCT05983796
18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.
Prospective Study of 18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a open-label, one-arm, multicenter study aimed to explore the efficacy and safety of 18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 18F-HER2 PET | 18F-HER2 PET |
Timeline
- Start date
- 2023-08-10
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
- First posted
- 2023-08-09
- Last updated
- 2023-08-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05983796. Inclusion in this directory is not an endorsement.